Astellas Pharma ADR GAAP EPS of v134.47, revenue of ¥1270.86B; updates FY2027 outlook
Source: Seeking Alpha ·
Read the full story at Seeking Alpha
Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.
More from the world desk
- Key moments from a night of midterm election firsts BBC World
- Novo improves outlook on continued demand for Wegovy pill, Ozempic Seeking Alpha
- European shares advance, euro hits one-month high after U.S. election Seeking Alpha
- 5 midterm election takeaways: Tech billionaires suffer as Democrats drub Republicans CNBC Markets
- SSGC announces winter gas supply schedule for Sindh, Balochistan Dawn
- What Trump losing power over Congress means for Iran, Ukraine and foreign policy CNBC Markets